grant

Development of a humanised antibody for treatment of cancer and stroke [ 2012 - 2013 ]

Also known as: Development of an antibody for treatment of cancer and stroke

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1038334]

Researchers: Prof Andrew Scott (Principal investigator)

Brief description The protein PDGF-CC has a critical role in blood vessel development, and is implicated in the development of cancer, and the debilitating consequences of acute stroke. Researchers in the Ludwig Institute for Cancer Research have developed novel anti-PDGF-CC antibodies. The research program proposed will generate data and clinical reagents that will enable a lead candidate anti-PDGF-CC antibody to be commercialised, and ultimately evaluated clinically in cancer and stroke patients.

Funding Amount $AUD 400,142.82

Funding Scheme NHMRC Development Grants

Notes Development Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857